OverviewChartNewsTraderScreen

Soc. Generale Put 35 QIA 20.12.20.../  DE000SU9M0F0  /

Frankfurt Zert./SG
10/16/2024  2:24:52 PM Chg.-0.002 Bid3:20:53 PM Ask3:20:53 PM Underlying Strike price Expiration date Option type
0.042EUR -4.55% 0.043
Bid Size: 50,000		 0.053
Ask Size: 50,000		 QIAGEN NV 35.00 EUR 12/20/2024 Put
GlobeNewswire 8/28 QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in c...
TeleTrader 8/26 Europe closes mixed amid Middle East crisis
GlobeNewswire 7/31 QIAGEN delivers solid performance and exceeds outlook for Q2 2024
GlobeNewswire 7/31 Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
GlobeNewswire 7/8 QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
GlobeNewswire 7/2 QIAGEN N.V. to release results for Q2 2024 and hold webcast
GlobeNewswire 6/27 QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis in...
GlobeNewswire 6/17 QIAGEN announces 2028 strategy for solid profitable growth
GlobeNewswire 6/13 QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire 6/12 QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire 6/11 QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire 6/6 QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire 6/5 QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire 6/3 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 5/30 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 5/30 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 5/29 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 5/22 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 5/14 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 5/13 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 5/7 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 5/7 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 5/7 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 5/2 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 4/29 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance